Navigation Links
Minimally Invasive Ear Implant Procedures Are Better

Cochlear implants for ears, which are done in a minimally invasive procedure, are better than those done following the traditional way. Researchers from University of Texas Health Science Center will present this research finding // at the 109th Annual Meeting & OTO EXPO of the American Academy of Otolaryngology—Head and Neck Surgery Foundation.

Traditional cochlear implantation involved a large scalp flap, mastoidectomy (a surgical removal of the mastoid air cells), posterior tympanotomy via the facial recess, creating an opening in the cochlea, and insertion of the electrode into the scala tympani.

Researchers in Texas propose minimally invasive cochlear implantation (MICI) as a technique in which creation of a large scalp flap is avoided, thereby reducing complications. The most common complications with cochlear implantation involve flap breakdown and electrode misplacement. With the MICI, the large scalp flap has been replaced with creation of a subperiostial pocket for the cochlear implant device.

MICI requires a 3-4 cm long post auricular incision placed approximately 1.0cm posterior to the postauricular crease. The decreased tissue trauma and edema has permitted postoperative day one programming and use of the cochlear implant (CI).

Of the one hundred seventy-six patients were included in the study, results had showed that seven major complications were recorded; six patients necessitated revision surgery. Three patients had device failure, including intermittent lock, requiring replacement of their cochlear implant. Three out of seven of the major complications were due to cochlear implant device failure, and not attributable to MICI surgery itself.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Any Form Of Minimally Invasive Surgery- Name It & They Do It!
2. Minimally Invasive Lung Cancer Surgery Minimize the Treatment Timings
3. Minimally Invasive Procedure Restores Sagging Facial Skin without Heavy Lifting
4. New, Minimally-Invasive Surgery for the Morbidly Obese
5. Lesser the Better- Minimally Invasive Surgery Breakthrough
6. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
7. Preventing Strokes Using Less Invasive Techniques
8. The Use Of Invasive Treatment For Life Threatening Heart Conditions Questioned
9. Surgery For Obesity May Need Invasive Monitoring
10. Invasive Skin Cancer On The Rise in Hispanics
11. Any Form Of Minimally Invasive Surgery- Name It & They Do It!
Post Your Comments:
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... enzyme which is discovered, may interpret the reasons for ... the UK) is known to relieve pain and fever, ... too and are known as non-steroidal anti-inflammatory agents (NSAIDs). ... cyclo-oxygenase (COX)-1 and COX-2. It is COX-2 which generates ...
... of Switzerland finds children who are exposed to greater levels ... or allergies. Researchers had parents of children ages 7 to ... also took blood samples from the kids to test for ... the children's bedding to test for levels of endotoxin, a ...
... irritability and dullness are common among people who have mild ... Cardiovascular Health Study is the largest ever investigation into heart ... 3,000 people in the US, some of who had a ... memory loss. ,Researchers at Wake Forest University now ...
... smokers have always been at a loss when it comes ... source of environmental tobacco smoke for residents. Environmental tobacco smoke// ... adverse health effects - from exacerbation of asthma to eye ... banned in the workplace and in public places. Researchers at ...
... study, researchers found that the treatment naltrexone is effective ... Researchers of alcohol often distinguish two patterns of drinking// ... are saved up for the weekend and holidays, and ... and often with meals. The Anglo-Saxon pattern has been ...
... a new study, children of people with mood disorders who ... their own lives as well. The link is especially strong ... women who suffer from mood disorders themselves. ,Research has ... increased risk of committing suicide, but few studies have looked ...
Other Medicine News:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... -- Additional Findings Reported Safety & Tolerability ... Healthy Subjects --, CHICAGO, June 25, 2007 ... at the annual meeting of the American ... (DPP-4) in development by Bristol-Myers,Squibb Company and ...
... WIRE)--Jun 27, 2007 - CytRx Corporation,(NASDAQ:CYTR), a ... of human therapeutics, today,announced promising data from ... IIa clinical trial with arimoclomol in ALS,volunteers. ... at a 100 mg dose three times ...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 2CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 3CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 4CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 5
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ... 1.5C Remelt Point (1.5%): 88.0 1.5C ... 1,200 gm/cm 2 Gel Strength (1.5%): greater ... Moisture: less than or equal to 7% Turbidity ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... Application: Forms strong flexible gels ... ID clarifier: mixture of wide ... Solubility: water 10 mg/mL, clear, ... for molecular biology MP: 90 ...
Inquire...
Medicine Products: